Related Experiment Video
Updated: Jul 20, 2026
Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
Reactive oxygen species in cancer cells: live by the sword, die by the sword
1Department of Pediatrics, Northwestern University, Chicago, Illinois 60611, USA. p-schumacker@northwestern.edu <p-schumacker@northwestern.edu>
Abstract:
Reactive oxygen species and tumor biology are intertwined in a complex web, making it difficult to understand which came first, whether oxidants are required for tumor cell growth, and whether oxidant stress can be exploited therapeutically. Evidence suggests that transformed cells use ROS signals to drive proliferation and other events required for tumor progression. This confers a state of increased basal oxidative stress, making them vulnerable to chemotherapeutic agents that further augment ROS generation or that weaken antioxidant defenses of the cell. In this respect, it appears that tumor cells may die by the same systems they require.
Insights
Tumor cells rely on reactive oxygen species (ROS) for growth and progression. This dependence on ROS makes cancer cells vulnerable to therapies that disrupt their oxidative balance, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- The relationship between reactive oxygen species (ROS) and tumor biology is complex and not fully understood.
- Investigating the necessity of oxidants for tumor cell proliferation and the potential for therapeutic exploitation of oxidant stress.
Discussion:
- Transformed cells utilize ROS signaling pathways to promote proliferation and tumor progression.
- Elevated basal oxidative stress in cancer cells creates a vulnerability.
- This vulnerability can be targeted by chemotherapeutic agents that increase ROS generation or impair antioxidant defenses.
Key Insights:
- Tumor cells exhibit increased basal oxidative stress due to their reliance on ROS for growth.
- Cancer cells are susceptible to therapies that exacerbate oxidative stress.
- The same systems tumor cells require for survival may also be exploited for their destruction.
Outlook:
- Developing targeted therapies that specifically exploit the ROS dependency of cancer cells.
- Further research into the dual role of ROS in cancer progression and potential treatment.
- Understanding the intricate balance of ROS and antioxidant systems in cancer therapy.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
01:29Oxygen Requirements and Growth Patterns